MedPath

Comparing Insertion Of ProSeal Airway Device With Introducer Tool With Stylet And Without Stylet

Not yet recruiting
Conditions
Paediatric patients posted for elective surgery under General Anaesthesia
Registration Number
CTRI/2022/11/047791
Lead Sponsor
Dr. NAMITA ARORA
Brief Summary

Patients, who fulfill the inclusion criteria, will participate in the study. They will be computerised randomisation where they will be divided into two groups IT -   65 patients and ST  - 65 patients.

In IT group, the PLMA will be inserted with an introducer tool, followed by clinical assessment and assessment by fibreoptic bronchoscope.

In ST group, the PLMA will be inserted using a stylet, followed by clinical assessment and assessment with fibreoptic bronchoscope.

Based on a five-point scale by CHen et al, grading of glottic view on fibreoptic bronchoscopy will be done.

Grade  and 4 are acceptable placement, whereas grades 0,1,2 are not acceptable and require endotracheal tube intubation.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
130
Inclusion Criteria
  • ASA Status I and II 2.
  • Elective Surgery under General Anaesthesia.
Exclusion Criteria
  • Anticipated Difficult Airway 2.
  • Airway related surgery, posttonsillectomy 3.
  • Emergency Surgery 4.
  • Children with cardio-respiratory disease, URTI, Hiatus Hernia, Full stomach, History of convulsions.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fibreoptic Bronchoscopic grading of PLMA placementRealtime
Secondary Outcome Measures
NameTimeMethod
1. Number of attempts for insertion2. Total time taken for successful insertion(seconds)

Trial Locations

Locations (1)

ABVIMS And Dr. Ram Manohar Lohia Hospital

🇮🇳

Delhi, DELHI, India

ABVIMS And Dr. Ram Manohar Lohia Hospital
🇮🇳Delhi, DELHI, India
Dr Neha Pandey
Principal investigator
9205415492
neehapaandey26@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.